PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

Patients with squamous cell cancer of neck nodes but unknown primary will have a PET-CT scan prior to biopsies. The utility of PET-CT will be determined in this subset of patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Squamous Cell Cancer Neoplasms Neoplasms by Histologic Type Neoplasms, Glandular and Epithelial Neoplasms, Squamous Cell

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Tom Baker Cancer Centre

Calgary, Alberta, T2N 4N2, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

squamous cell cancer of neck nodes with unknown primary site

Exclusion criteria

unable to tolerate PET-CT
unable to undergo examination under anaesthesia

Treatment and study plan

PET-CT

Other

Sponsors and collaborators

Lead sponsor

AHS Cancer Control Alberta

Other

Collaborators

Calgary Health Region
University of Calgary

Registry information

Official study title

The Clinical Utility of PET-CT in the Management of Squamous Cell Carcinoma of the Neck Nodes With Unknown Primary Malignancy

Important dates

Study start: 2007
Primary completion: 2010
Study completion: 2010
First posted: Sep 17, 2007
Registry last updated: Oct 21, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed